{"id":"3ff7a5a1-3c3e-48a7-8a07-1e3dcd200da8","name":"Precision Neuroscience","slug":"precision-neuroscience","description":"Precision Neuroscience is a New York-based brain-computer interface company developing the [Layer 7 Cortical Interface](/models/precision-layer-7-cortical-interface), a minimally invasive, safely removable BCI with 1,024 electrodes on a thin flexible film. FDA 510(k) clearance granted April 2025 — first full regulatory clearance for a next-generation wireless BCI. Tested in 37 patients across Mount Sinai, Penn Medicine, WVU Rockefeller Neuroscience Institute, and Beth Israel. Raised $161M total (Series B $41M, Series C $120M).","status":"private","founded":2021,"hq":"New York, New York, USA","hqLat":40.7127281,"hqLng":-74.0060152,"hqGeocodedAt":"2026-08-23T20:59:31.229Z","hqAddress":null,"hqPrecision":null,"website":"https://www.precisionneuro.io","fundingTotal":"120000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":53,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.precisionneuro.io/","title":"Precision Neuroscience — Layer 7 Cortical Interface BCI","sourceName":"Precision Neuroscience (official)"},{"url":"https://www.biorxiv.org/content/10.1101/2022.01.02.474656v1","title":"The Layer 7 Cortical Interface: A scalable and minimally invasive neural interface","sourceName":"bioRxiv"},{"url":"https://www.precisionneuro.io/our-technology","title":"Our Technology","sourceName":"Precision Neuroscience"},{"url":"https://www.precisionneuro.io/articles/company-news/precision-neuroscience-receives-fda-clearance-for-high-resolution-cortical-electrode-array","date":"2025-04-17","title":"Precision Neuroscience Receives FDA Clearance for High-Resolution Cortical Electrode Array","sourceName":"Precision Neuroscience"}],"keyFacts":[{"label":"Layer 7 (company-claimed)","value":"Cortical array thinner than a hair with 1,024 electrodes that rests on the brain without penetrating."},{"label":"FDA clearance (company-claimed)","value":"510(k) clearance for Layer 7 for recording and stimulation for up to 30 days."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:26:44.153Z","updatedAt":"2026-10-12T22:29:39.032Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/precision-neuroscience","url":"https://registry.deploy.report/companies/precision-neuroscience","name":"Precision Neuroscience","description":"Precision Neuroscience is a New York-based brain-computer interface company developing the [Layer 7 Cortical Interface](/models/precision-layer-7-cortical-interface), a minimally invasive, safely removable BCI with 1,024 electrodes on a thin flexible film. FDA 510(k) clearance granted April 2025 — first full regulatory clearance for a next-generation wireless BCI. Tested in 37 patients across Mount Sinai, Penn Medicine, WVU Rockefeller Neuroscience Institute, and Beth Israel. Raised $161M total (Series B $41M, Series C $120M).","identifier":"3ff7a5a1-3c3e-48a7-8a07-1e3dcd200da8","foundingDate":"2021","address":"New York, New York, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":4,"primary_source_types":["primary-company-ir"]}}}